(Q48879558)

16 February 2018

title

Early identification of poor responders to transarterial chemoembolization for hepatocellular carcinoma. (English)

1 reference

16 February 2018

author

Yi-Hsiang Huang

3

1 reference

16 February 2018

author name string

Ya-Ju Tsai

1

1 reference

16 February 2018

Chia-Yang Hsu

2

1 reference

16 February 2018

Chien-Wei Su

4

1 reference

16 February 2018

Han-Chieh Lin

5

1 reference

16 February 2018

Rheun-Chuan Lee

6

1 reference

16 February 2018

Jen-Huey Chiang

7

1 reference

16 February 2018

Teh-Ia Huo

8

1 reference

16 February 2018

Shou-Dong Lee

9

1 reference

16 February 2018

publication date

30 April 2011

1 reference

16 February 2018

published in

Hepatology international

1 reference

16 February 2018

volume

5

1 reference

16 February 2018

issue

4

1 reference

16 February 2018

page(s)

975-984

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/s12072-011-9276-9

exact match

0 references

cites work

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Hepatocellular carcinoma in the Asia pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Treatment of non-resectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9276-9

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization

21 January 2018

1 reference

12 December 2020

Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery

1 reference

12 December 2020

A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System

1 reference

12 December 2020

Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. CLIP Group (Cancer of the Liver Italian Programme)

1 reference

12 December 2020

Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency

1 reference

12 December 2020

Epidemiology of alcoholic liver disease

1 reference

12 December 2020

Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma

1 reference

12 December 2020

Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center

1 reference

12 December 2020

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

12 December 2020

Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy

1 reference

12 December 2020

Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators

1 reference

12 December 2020

10.1007/S12072-011-9276-9

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018